Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEGIS: Axert for Early Acute Migraine Treatment
NCT00210509Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2004
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of almotriptan in migraine, sponsored by Janssen Pharmaceutical. Started Nov 2004; status: completed.
02
Drugs
almotriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00210509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210509.